NEK2 and AL amyloidosis: In a previous study, we showed that the AKT inhibitor LY294002 and β-catenin shRNA decrease the NEK2A induced colony formation in multiple myeloma, suggesting that both PP1/AKT and the Wnt signaling pathway may be involved in NEK2A-induced cell proliferation [12].